Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Personal Finance

AbbVie : ABBV

All AbbVie Articles

633 Articles

Drew Wood | Jun 26, 2026 at 7:03 AM EDT

The Homebody Portfolio: How Much Does Retirement Cost When You Never Leave Chicago?

What does retirement look like for someone who genuinely has no desire to leave home? No snowbird condo in Florida.…

Trey Thoelcke | Jun 25, 2026 at 8:15 AM EDT

3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree

Big pharma is hunting again, and patent cliffs are forcing buyers to overpay or miss out. Three mid-cap biotechs have…

Alex Sirois | Jun 24, 2026 at 4:33 PM EDT

Why I Can’t Stop Buying This Unstoppable Dividend Juggernaut

I hit the buy button on AbbVie (NYSE:ABBV | ABBV Price Prediction) again last week, and I will hit it…

Drew Wood | Jun 24, 2026 at 11:38 AM EDT

The Dividend Portfolio That Starts Like A Honda And Ends Like A Ferrari

Most retirees shop for dividend portfolios the same way people shop for cars: they focus on what they get today.…

Alex Sirois | Jun 24, 2026 at 10:02 AM EDT

64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital

At 64, with $1.1 million in a Traditional IRA, tax-deferred cash flow is the point. With the 10-year Treasury at…

Trey Thoelcke | Jun 24, 2026 at 7:55 AM EDT

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching

Big Pharma's patent cliffs are forcing acquirers to hunt for revenue-producing biotech assets before rivals snap them up, and three…

Trey Thoelcke | Jun 23, 2026 at 7:55 AM EDT

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

Big pharma’s appetite for clinical-stage biotech is back. The pending acquisition of Apogee Therapeutics by AbbVie (NYSE: ABBV | ABBV…

Marc Guberti | Jun 21, 2026 at 4:17 PM EDT

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

The Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is having a frustrating year. The fund sits at $149, down about…

Drew Wood | Jun 19, 2026 at 2:56 PM EDT

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

Ten thousand dollars a month works out to $120,000 a year, an income stream that exceeds the roughly $68,359 in…

Joel South | Jun 17, 2026 at 1:05 PM EDT

3 Dividend Stocks That Pay You More Every Single Year

Income investors keep coming back to the same playbook in choppy markets: own businesses that have raised their payouts every…

Drew Wood | Jun 17, 2026 at 8:59 AM EDT

How to Build $5,000 a Month in Dividend Income and Never Touch Your Principal

Five thousand dollars a month is the income many retirees are trying to generate from their investments. It is enough to…

Alex Sirois | Jun 16, 2026 at 4:42 PM EDT

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

For income investors weighing biopharma exposure, the dividend question on AbbVie (NYSE:ABBV | ABBV Price Prediction) just got a lot…

Vandita Jadeja | Jun 16, 2026 at 1:30 PM EDT

AbbVie Stock Will Hit $300 on This Date

AbbVie (NYSE:ABBV | ABBV Price Prediction) has quietly become one of healthcare’s most underrated growth stories. CEO Robert A. Michael…

Michael Williams | Jun 16, 2026 at 6:12 AM EDT

SCHD Now Concentrates 42% of Your Money in Just 10 Stocks. Here Is Who Should Still Own It

Most Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) owners assume they are buying broad market diversification. The latest Schwab fact sheet…

Drew Wood | Jun 15, 2026 at 2:59 PM EDT

The Retiree Who Chose $65,000 Instead of $120,000 and Ended Up Richer

Two retirees walk into retirement with the same amount of money. One builds a portfolio that pays $120,000 a year…

1 2 3 4 5 … 43

AbbVie : ABBV

All AbbVie Articles

The Homebody Portfolio: How Much Does Retirement Cost When You Never Leave Chicago?

3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree

Why I Can’t Stop Buying This Unstoppable Dividend Juggernaut

The Dividend Portfolio That Starts Like A Honda And Ends Like A Ferrari

64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

3 Dividend Stocks That Pay You More Every Single Year

How to Build $5,000 a Month in Dividend Income and Never Touch Your Principal

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

AbbVie Stock Will Hit $300 on This Date

SCHD Now Concentrates 42% of Your Money in Just 10 Stocks. Here Is Who Should Still Own It

The Retiree Who Chose $65,000 Instead of $120,000 and Ended Up Richer

Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Live: Will Intuit’s Q4 Earnings Tonight Extend the Stock’s 25% Rebound?

Live: Will Zoom Crush Tonight’s Q2 Earnings After the Bell?

ServiceNow Just Ripped 29% in a Month. What Would It Take to Get NOW Stock Up to $150?

Microsoft Just Ripped 28% in a Month. What Would It Take to Get MSFT Stock Up to $600?

Wall Street Just Invented the ‘Neocloud’ ETF. It Owns the Companies Renting AI Compute to Everyone Else

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.

Clark Howard Warned Apple Traps You in Forever Leases and Now Three New Macs Just Landed

Merck Just Gained 19% in a Month. What Would It Take to Get MRK Stock Up to $200?

ServiceNow Just Ripped 29% in a Month. What Would It Take to Get NOW Stock Up to $150?

AbbVie : ABBV

All AbbVie Articles

The Homebody Portfolio: How Much Does Retirement Cost When You Never Leave Chicago?

3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree

Why I Can’t Stop Buying This Unstoppable Dividend Juggernaut

The Dividend Portfolio That Starts Like A Honda And Ends Like A Ferrari

64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

3 Dividend Stocks That Pay You More Every Single Year

How to Build $5,000 a Month in Dividend Income and Never Touch Your Principal

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

AbbVie Stock Will Hit $300 on This Date

SCHD Now Concentrates 42% of Your Money in Just 10 Stocks. Here Is Who Should Still Own It

The Retiree Who Chose $65,000 Instead of $120,000 and Ended Up Richer

Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Live: Will Intuit’s Q4 Earnings Tonight Extend the Stock’s 25% Rebound?

Live: Will Zoom Crush Tonight’s Q2 Earnings After the Bell?

ServiceNow Just Ripped 29% in a Month. What Would It Take to Get NOW Stock Up to $150?

Microsoft Just Ripped 28% in a Month. What Would It Take to Get MSFT Stock Up to $600?

Wall Street Just Invented the ‘Neocloud’ ETF. It Owns the Companies Renting AI Compute to Everyone Else

Featured Reads

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.

Clark Howard Warned Apple Traps You in Forever Leases and Now Three New Macs Just Landed